Molecular characteristics of Neisseria meningitidis strains isolated in Burkina Faso in 2001
- PMID: 12578146
Molecular characteristics of Neisseria meningitidis strains isolated in Burkina Faso in 2001
Abstract
In the course of an epidemic of meningitis in Burkina Faso in 2001, 27 cerebrospinal fluid samples from patients in 7 districts were forwarded to Norway for isolation and characterization of the causative agents. Neisseria meningitidis was isolated from 13 (48%) samples. The isolates were analysed using serological and genetic methods. Of the 13 strains, 4 were serogroup A, serotype 21:P1.9, sequence type (ST)-5 and belonged to clonal subgroup III, while the remaining 9 strains were serogroup W135, serotype 2a:P1.5,2, ST-11 and belonged to the electrophoretic type-37 complex. PCR analyses revealed meningococcal DNA in 13/14 culture-negative samples. Sequence analysis of the PCR products demonstrated that at least 3 different meningococcal strains were responsible for these 13 cases. Our results show that the W135 strain associated with the 2000 hajj (Muslim pilgrimage) outbreak was a significant cause of disease in Burkina Faso in 2001. Further studies are warranted to determine whether W135 is about to replace serogroup A in sub-Saharan Africa.
Similar articles
-
The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005.Clin Infect Dis. 2006 Oct 1;43(7):817-22. doi: 10.1086/507339. Epub 2006 Aug 22. Clin Infect Dis. 2006. PMID: 16941360
-
Bacterial meningitis in Burkina Faso: surveillance using field-based polymerase chain reaction testing.Clin Infect Dis. 2005 Jan 1;40(1):17-25. doi: 10.1086/426436. Epub 2004 Dec 8. Clin Infect Dis. 2005. PMID: 15614687
-
Epidemiological and molecular characteristics of a highly lethal pneumococcal meningitis epidemic in Burkina Faso.Clin Infect Dis. 2006 Sep 15;43(6):693-700. doi: 10.1086/506940. Epub 2006 Aug 15. Clin Infect Dis. 2006. PMID: 16912941
-
Meningococcal serogroup W135 in the African meningitis belt: epidemiology, immunity and vaccines.Expert Rev Vaccines. 2006 Jun;5(3):319-36. doi: 10.1586/14760584.5.3.319. Expert Rev Vaccines. 2006. PMID: 16827617 Review.
-
[Clonal expansion of Neisseria meningitidis W135. Epidemiological implications for the African meningitis belt].Bull Soc Pathol Exot. 2002 Dec;95(5):323-4; discussion 324-5. Bull Soc Pathol Exot. 2002. PMID: 12696368 Review. French.
Cited by
-
Molecular characteristics and epidemiology of meningococcal carriage, Burkina Faso, 2003.Emerg Infect Dis. 2007 Jun;13(6):847-54. doi: 10.3201/eid1306.061395. Emerg Infect Dis. 2007. PMID: 17553222 Free PMC article.
-
Neisseria meningitidis: biology, microbiology, and epidemiology.Methods Mol Biol. 2012;799:1-20. doi: 10.1007/978-1-61779-346-2_1. Methods Mol Biol. 2012. PMID: 21993636 Free PMC article. Review.
-
Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine.PLoS One. 2012;7(9):e46019. doi: 10.1371/journal.pone.0046019. Epub 2012 Sep 27. PLoS One. 2012. PMID: 23029368 Free PMC article.
-
Meningococcal vaccines.Paediatr Drugs. 2004;6(4):251-66. doi: 10.2165/00148581-200406040-00004. Paediatr Drugs. 2004. PMID: 15339202 Review.
-
Preparedness for infectious threats: public-private partnership to develop an affordable vaccine for an emergent threat: the trivalent Neisseria meningitidis ACW135 polysaccharide vaccine.Am J Public Health. 2007 Apr;97 Suppl 1(Suppl 1):S15-22. doi: 10.2105/AJPH.2005.075085. Epub 2007 Apr 5. Am J Public Health. 2007. PMID: 17413077 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical